Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurological Research and Practice
Published in: Neurological Research and Practice 1/2024

Open Access 01-12-2024 | Venous Thrombosis | Guidelines

New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline

Authors: C Weimar, J Beyer-Westendorf, FO Bohmann, G Hahn, S Halimeh, S Holzhauer, C Kalka, M Knoflach, H-C Koennecke, F Masuhr, M-L Mono, U Nowak-Göttl, E Scherret, M Schlamann, B Linnemann

Published in: Neurological Research and Practice | Issue 1/2024

Login to get access

Abstract

Over the last years, new evidence has accumulated on multiple aspects of diagnosis and management of cerebral venous and dural sinus thrombosis (CVT) including identification of new risk factors, studies on interventional treatment as well as treatment with direct oral anticoagulants. Based on the GRADE questions of the European Stroke Organization guideline on this topic, the new German guideline on CVT is a consensus between expert representatives of Austria, Germany and Switzerland. New recommendations include:
• CVT occurring in the first weeks after SARS-CoV-2 vaccination with vector vaccines may be associated with severe thrombocytopenia, indicating the presence of a prothrombotic immunogenic cause (Vaccine-induced immune thrombotic thrombocytopenia; VITT).
• D-dimer testing to rule out CVT cannot be recommended and should therefore not be routinely performed.
• Thrombophilia screening is not generally recommended in patients with CVT. It should be considered in young patients, in spontaneous CVT, in recurrent thrombosis and/or in case of a positive family history of venous thromboembolism, and if a change in therapy results from a positive finding.
• Patients with CVT should preferably be treated with low molecular weight heparine (LMWH) instead of unfractionated heparine in the acute phase.
• On an individual basis, endovascular recanalization in a neurointerventional center may be considered for patients who deteriorate under adequate anticoagulation.
• Despite the overall low level of evidence, surgical decompression should be performed in patients with CVT, parenchymal lesions (congestive edema and/or hemorrhage) and impending incarceration to prevent death.
• Following the acute phase, oral anticoagulation with direct oral anticoagulants instead of vitamin K antagonists should be given for 3 to 12 months to enhance recanalization and prevent recurrent CVT as well as extracerebral venous thrombosis.
• Women with previous CVT in connection with the use of combined hormonal contraceptives or pregnancy shall refrain from continuing or restarting contraception with oestrogen–progestagen combinations due to an increased risk of recurrence if anticoagulation is no longer used.
• Women with previous CVT and without contraindications should receive LMWH prophylaxis during pregnancy and for at least 6 weeks post partum.
Although the level of evidence supporting these recommendations is mostly low, evidence from deep venous thrombosis as well as current clinical experience can justify the new recommendations.
This article is an abridged translation of the German guideline, which is available online.
Literature
1.
Weimar, C., Beyer-Westendorf, J., Linnemann, B., Bohmann, F. O., Hahn, G., Halimeh, S., Holzhauer, S., Kalka, C., Knoflach, M., Koennecke, H.-C., Masuhr, F., Mono, M.-L., Nowak-Göttl, U., Scherret, E., Schlamann, M. (2023). Zerebrale Venen- und Sinusthrombose – AWMF-S2k-Leitlinie. Retrieved 13.03.2024, from https://​register.​awmf.​org/​de/​leitlinien/​detail/​030-098
2.
Ferro, J. M., Bousser, M. G., Canhao, P., Coutinho, J. M., Crassard, I., Dentali, F., di Minno, M., Maino, A., Martinelli, I., Masuhr, F., Aguiar de Sousa, D., Stam, J., & European Stroke, O. (2017). European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. European Journal of Neurology, 24(10), 1203–1213.PubMedCrossRef
3.
Riva, N., & Ageno, W. (2017). Approach to thrombosis at unusual sites: Splanchnic and cerebral vein thrombosis. Vascular Medicine, 22(6), 529–540.PubMedCrossRef
4.
Kenet, G., Kirkham, F., Niederstadt, T., Heinecke, A., Saunders, D., Stoll, M., Brenner, B., Bidlingmaier, C., Heller, C., Knofler, R., Schobess, R., Zieger, B., Sebire, G., Nowak-Gottl, U., European Thromboses Study, G. (2007). Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: A multicentre cohort study. Lancet Neurology, 6(7), 595–603.CrossRef
5.
Kenet, G., Lutkhoff, L. K., Albisetti, M., Bernard, T., Bonduel, M., Brandao, L., Chabrier, S., Chan, A., deVeber, G., Fiedler, B., Fullerton, H. J., Goldenberg, N. A., Grabowski, E., Gunther, G., Heller, C., Holzhauer, S., Iorio, A., Journeycake, J., Junker, R., Kirkham, F. J., Kurnik, K., Lynch, J. K., Male, C., Manco-Johnson, M., Mesters, R., Monagle, P., van Ommen, C. H., Raffini, L., Rostasy, K., Simioni, P., Strater, R. D., Young, G., Nowak-Gottl, U. (2010). Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: A systematic review and meta-analysis of observational studies. Circulation, 121(16), 1838–1847.PubMedCrossRef
6.
Linnemann, B., Blank, W., Doenst, T., Erbel, C., Isfort, P., Janssens, U., Kalka, C., Klamroth, R., Kotzerke, J., Ley, S., Meyer, J., Mühlberg, K., Müller, O. J., Noppeney, T., Opitz, C., Riess, H., Solomayer, E.-F., Volk, T., Beyer-Westendorf, J. (2023). Diagnostik und Therapie der tiefen Venenthrombose und Lungenembolie – AWMF-S2k-Leitlinie. Retrieved 11.04.2023, from https:/register.awmf.org/de/leitlinien/detail/065–002
7.
8.
Garcia, D. A., Baglin, T. P., Weitz, J. I., & Samama, M. M. (2012). Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141(2 Suppl), e24S-e43S.PubMedPubMedCentralCrossRef
9.
10.
Qureshi, A., & Perera, A. (2017). Low molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: A systematic review and meta-analysis. Annals of Medicine Surgery (Lond), 17, 22–26.CrossRef
11.
Coutinho, J. M., Zuurbier, S. M., Bousser, M. G., Ji, X., Canhao, P., Roos, Y. B., Crassard, I., Nunes, A. P., Uyttenboogaart, M., Chen, J., Emmer, B. J., Roosendaal, S. D., Houdart, E., Reekers, J. A., van den Berg, R., de Haan, R. J., Majoie, C. B., Ferro, J. M., Stam, J., & investigators, T.-A. (2020). Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial. JAMA Neurology, 77(8), 966–973.PubMedPubMedCentralCrossRef
12.
13.
Lewis, W., Saber, H., Sadeghi, M., Rajah, G., & Narayanan, S. (2019). Transvenous Endovascular Recanalization for Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis. World Neurosurgery, 130, 341–350.PubMedCrossRef
14.
Avanali, R., Gopalakrishnan, M. S., Devi, B. I., Bhat, D. I., Shukla, D. P., & Shanbhag, N. C. (2019). Role of Decompressive Craniectomy in the Management of Cerebral Venous Sinus Thrombosis. Frontiers of Neurology, 10, 511.CrossRef
15.
Mohamed, M. W. F., Aung, S. S., Mereddy, N., Ramanan, S. P., & Hamid, P. (2020). Role, Effectiveness, and Outcome of Decompressive Craniectomy for Cerebral Venous and Dural Sinus Thrombosis (CVST): Is Surgery Really an Option? Cureus, 12(12), e12135.PubMedPubMedCentral
16.
Ferro, J. M., Coutinho, J. M., Dentali, F., Kobayashi, A., Alasheev, A., Canhao, P., Karpov, D., Nagel, S., Posthuma, L., Roriz, J. M., Caria, J., Frassdorf, M., Huisman, H., Reilly, P., Diener, H. C., Group, R.-S. C. S. (2019). Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial. JAMA Neurology, 76(12), 1457–1465.CrossRef
17.
Connor, P., Sanchez van Kammen, M., Lensing, A. W. A., Chalmers, E., Kallay, K., Hege, K., Simioni, P., Biss, T., Bajolle, F., Bonnet, D., Grunt, S., Kumar, R., Lvova, O., Bhat, R., Van Damme, A., Palumbo, J., Santamaria, A., Saracco, P., Payne, J., … Coutinho, J. M. (2020). Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT). Blood Advances, 4(24), 6250–6258.PubMedPubMedCentralCrossRef
18.
Nepal, G., Kharel, S., Bhagat, R., Ka Shing, Y., Ariel Coghlan, M., Poudyal, P., Ojha, R., & Sunder Shrestha, G. (2022). Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis. Acta neurologica Scandinavica, 145(1), 10–23.PubMedCrossRef
19.
deVeber, G., Andrew, M., Adams, C., Bjornson, B., Booth, F., Buckley, D. J., Camfield, C. S., David, M., Humphreys, P., Langevin, P., MacDonald, E. A., Gillett, J., Meaney, B., Shevell, M., Sinclair, D. B., Yager, J., Canadian Pediatric Ischemic Stroke Study, G. (2001). Cerebral sinovenous thrombosis in children. The New England journal of medicine, 345(6), 417–423.CrossRef
20.
Ichord, R. N., Benedict, S. L., Chan, A. K., Kirkham, F. J., Nowak-Gottl, U., International Paediatric Stroke Study, G. (2015). Paediatric cerebral sinovenous thrombosis: Findings of the International Paediatric Stroke Study. Archives of disease in childhood, 100(2), 174–179.CrossRef
21.
Musgrave, K. M., van Delft, F. W., Avery, P. J., Clack, R. M., Chalmers, E. A., Qureshi, A., Vora, A. J., & Biss, T. T. (2017). Cerebral sinovenous thrombosis in children and young adults with acute lymphoblastic leukaemia - a cohort study from the United Kingdom. British journal of haematology, 179(4), 667–669.PubMedCrossRef
22.
Glonnegger, H., Glatthaar, N., Eckenweiler, M., Barth, M., Uhl, M., Buchsel, M., & Zieger, B. (2023). Laboratory Findings, Medical Imaging, and Clinical Outcome in Children with Cerebral Sinus Venous Thrombosis. Hämostaseologie, 43(3), 188–195.PubMedCrossRef
23.
Sanchez van Kammen, M., Male, C., Connor, P., Monagle, P., Coutinho, J. M., Lensing, A. W. A., & investigators, E. I.-J. C. (2022). Anticoagulant Treatment for Pediatric Infection-Related Cerebral Venous Thrombosis. Pediatric Neurology, 128, 20–24.PubMedCrossRef
24.
Pengo, V., Denas, G., Zoppellaro, G., Jose, S. P., Hoxha, A., Ruffatti, A., Andreoli, L., Tincani, A., Cenci, C., Prisco, D., Fierro, T., Gresele, P., Cafolla, A., De Micheli, V., Ghirarduzzi, A., Tosetto, A., Falanga, A., Martinelli, I., Testa, S., … Banzato, A. (2018). Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood, 132(13), 1365–1371.PubMedCrossRef
25.
Pengo, V., Hoxha, A., Andreoli, L., Tincani, A., Silvestri, E., Prisco, D., Fierro, T., Gresele, P., Cafolla, A., De Micheli, V., Ghirarduzzi, A., Tosetto, A., Falanga, A., Martinelli, I., Testa, S., Barcellona, D., Gerosa, M., & Denas, G. (2021). Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure. Journal of thrombosis and haemostasis, 19(2), 531–535.PubMedCrossRef
26.
Aguiar de Sousa, D., Lucas Neto, L., Canhao, P., & Ferro, J. M. (2018). Recanalization in Cerebral Venous Thrombosis. Stroke, 49(8), 1828–1835.PubMedCrossRef
27.
Rezoagli, E., Martinelli, I., Poli, D., Scoditti, U., Passamonti, S. M., Bucciarelli, P., Ageno, W., & Dentali, F. (2018). The effect of recanalization on long-term neurological outcome after cerebral venous thrombosis. Journal of thrombosis and haemostasis, 16(4), 718–724.PubMedCrossRef
28.
Dentali, F., Gianni, M., Crowther, M. A., & Ageno, W. (2006). Natural history of cerebral vein thrombosis: A systematic review. Blood, 108(4), 1129–1134.PubMedCrossRef
29.
Arauz, A., Vargas-Gonzalez, J. C., Arguelles-Morales, N., Barboza, M. A., Calleja, J., Martinez-Jurado, E., Ruiz-Franco, A., Quiroz-Compean, A., & Merino, J. G. (2016). Time to recanalisation in patients with cerebral venous thrombosis under anticoagulation therapy. Journal ofNeurology, Neurosurgery, and Psychiatry, 87(3), 247–251.CrossRef
30.
Herweh, C., Griebe, M., Geisbusch, C., Szabo, K., Neumaier-Probst, E., Hennerici, M. G., Bendszus, M., Ringleb, P. A., & Nagel, S. (2016). Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis. European of Journal Neurology, 23(4), 681–687.CrossRef
31.
Nagaraja, D., Haridas, T., Taly, A. B., Veerendrakumar, M., & SubbuKrishna, D. K. (1999). Puerperal cerebral venous thrombosis: Therapeutic benefit of low dose heparin. Neurology India, 47(1), 43–46.PubMed
32.
Demir, C. F., Inci, M. F., Ozkan, F., Yildiz, M., & Ozdemir, H. (2013). Clinical and radiological management and outcome of pregnancies complicated by cerebral venous thrombosis: A review of 19 cases. Journal of stroke and cerebrovascular diseases, 22(8), 1252–1257.PubMedCrossRef
33.
Gao, H., Yang, B. J., Jin, L. P., & Jia, X. F. (2011). Predisposing factors, diagnosis, treatment and prognosis of cerebral venous thrombosis during pregnancy and postpartum: A case-control study. Chinise Medical Journal (Engl), 124(24), 4198–4204.
34.
Misra, U. K., Kalita, J., Chandra, S., Kumar, B., & Bansal, V. (2012). Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: A randomized controlled trial. European Journal of Neurology, 19(7), 1030–1036.PubMedCrossRef
35.
Linnemann, B., Scholz, U., Rott, H., Halimeh, S., Zotz, R., Gerhardt, A., Toth, B., Bauersachs, R., Working Group in Women’s Health of the Society of, T., Hemostasis. (2016). Treatment of pregnancy-associated venous thromboembolism - position paper from the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH). Vasa, 45(2), 103–118.CrossRef
36.
Daei, M., Khalili, H., & Heidari, Z. (2021). Direct oral anticoagulant safety during breastfeeding: A narrative review. European Journal of Clinical Pharmacology, 77(10), 1465–1471.PubMedCrossRef
37.
Riva, N., Dentali, F., Donadini, M. P., Squizzato, A., & Ageno, W. (2013). Risk of recurrence of unusual site venous thromboembolism. Hämostaseologie, 33(3), 225–231.PubMedCrossRef
38.
Palazzo, P., Agius, P., Ingrand, P., Ciron, J., Lamy, M., Berthomet, A., Cantagrel, P., & Neau, J. P. (2017). Venous Thrombotic Recurrence After Cerebral Venous Thrombosis: A Long-Term Follow-Up Study. Stroke, 48(2), 321–326.PubMedCrossRef
39.
Shu, L., Bakradze, E., Omran, S. S., Giles, J., Amar, J., Henninger, N., Elnazeir, M., Liberman, A., Moncrieffe, K., Rotblat, J., Sharma, R., Cheng, Y., Zubair, A. S., Simpkins, A., Li, G., Kung, J., Perez, D., Heldner, M. R., Scutelnic, A., & Yaghi, S. (2022). Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study. Neurology, 99(21), e2368–e2377.PubMedPubMedCentralCrossRef
40.
Amoozegar, F., Ronksley, P. E., Sauve, R., & Menon, B. K. (2015). Hormonal contraceptives and cerebral venous thrombosis risk: A systematic review and meta-analysis. Fronteirs Neurology, 6, 7.
41.
Beyer-Westendorf, J., Tittl, L., Bistervels, I., Middeldorp, S., Schaefer, C., Paulus, W., Thomas, W., Kemkes-Matthes, B., Marten, S., & Bornhauser, M. (2020). Safety of direct oral anticoagulant exposure during pregnancy: A retrospective cohort study. Lancet of Haematology, 7(12), e884–e891.PubMedCrossRef
42.
43.
Huttel, E., Padberg, S., Meister, R., Beck, E., & Schaefer, C. (2017). Pregnancy outcome of first trimester exposure to the vitamin K antagonist phenprocoumon depends on duration of treatment. Thrombosis and Haemostasis, 117(5), 870–879.PubMedCrossRef
44.
Martinelli, I., Lensing, A. W., Middeldorp, S., Levi, M., Beyer-Westendorf, J., van Bellen, B., Bounameaux, H., Brighton, T. A., Cohen, A. T., Trajanovic, M., Gebel, M., Lam, P., Wells, P. S., & Prins, M. H. (2016). Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use. Blood, 127(11), 1417–1425.PubMedPubMedCentralCrossRef
45.
Aguiar de Sousa, D., Canhao, P., & Ferro, J. M. (2016). Safety of Pregnancy After Cerebral Venous Thrombosis: A Systematic Review. Stroke, 47(3), 713–718.PubMedCrossRef
46.
Martinelli, I., Passamonti, S. M., Maino, A., Abbattista, M., Bucciarelli, P., Somigliana, E., Artoni, A., Gianniello, F., & Peyvandi, F. (2016). Pregnancy outcome after a first episode of cerebral vein thrombosis. Journal of Thrombosis Haemostasis, 14(12), 2386–2393.PubMedCrossRef
47.
Abbattista, M., Capecchi, M., & Martinelli, I. (2019). Pregnancy after cerebral venous thrombosis. Thrombosis Research, 181(Suppl 1), S15–S18.PubMedCrossRef
48.
Rottenstreich, A., Gershgoren, H., Spectre, G., Da’as, N., Bentur, O. S., Levin, G., & Kalish, Y. (2020). Factors associated with pregnancy outcomes in women with a history of cerebral sinus venous thrombosis. Journal of Thrombosis and Thrombolysis, 50(1), 151–156.PubMedCrossRef
49.
Poli, D., Cenci, C., Testa, S., Paoletti, O., Silvestri, E., & Antonucci, E. (2017). Obstetrical history of women with cerebral vein thrombosis: Outcome of the pregnancies before and after the thrombotic event. Internal Emergency Medicine, 12(7), 941–945.PubMedCrossRef
50.
Hart, C., Bauersachs, R., Scholz, U., Zotz, R., Bergmann, F., Rott, H., & Linnemann, B. (2020). Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH). Hämostaseologie, 40(5), 572–590.PubMedCrossRef
51.
Middleton, P., Shepherd, E., & Gomersall, J. C. (2021). Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period. Cochrane Database Systematic Reviews, 3(3), CD001689.
52.
Encke, A., Haas, S., Kopp, I., Abholz, H.-H., Bode, C., Bootz, F., Diener, H. C., Eggeling, S., Eikermann, M., Gerlach, H., Gogarten, W., Greinacher, A., Hach-Wunderle, V., Heidrich, H., Kneser, U., Krauspe, R., Krüger, C. M., Kujath, P., Kussmann, J., Mathes, T., Muhl, E., Nowak-Göttl, U., Pauschert, R., Protzel, C., Rabe, E., Riess, H., Rieß, F.-C., Rolle, U., Schellong, S., Schmitz-Rixen, T., Schwerdtfeger, K., Solomayer, E.-F., Spannagl, M., Stürmer, K., Swoboda, L., Ulsenheimer, K., von Haussen, T., Waydhas, C., Weigl, M. (2015). Prophylaxe der venösen Thromboembolie (VTE) – AWMF-S3-Leitlinie. Retrieved 13.03.2024, from https://​register.​awmf.​org/​de/​leitlinien/​detail/​003-001
53.
Monagle, P., Chalmers, E., Chan, A., deVeber, G., Kirkham, F., Massicotte, P., & Michelson, A. D. (2008). Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133(6 Suppl), 887S-968S.PubMedCrossRef
Metadata
Title
New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline
Authors
C Weimar
J Beyer-Westendorf
FO Bohmann
G Hahn
S Halimeh
S Holzhauer
C Kalka
M Knoflach
H-C Koennecke
F Masuhr
M-L Mono
U Nowak-Göttl
E Scherret
M Schlamann
B Linnemann
Publication date
01-12-2024

Other articles of this Issue 1/2024

Neurological Research and Practice 1/2024 Go to the issue

Clinical trial protocol

Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial

Research article

Functional long-term outcome following endovascular thrombectomy in patients with acute ischemic stroke

Research article

Trends in stroke severity at hospital admission and rehabilitation discharge before and during the COVID-19 pandemic in Hesse, Germany: a register-based study

Clinical trial protocol

Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis, the ProVal-MS study

Research article

Management of status epilepticus in pregnancy: a clinician survey

Research article

Characteristics associated with occurrence of stroke in patients with infective endocarditis – a retrospective cohort study